Search Orphan Drug Designations and Approvals
-
Generic Name: | elafibranor |
---|---|
Date Designated: | 07/25/2019 |
Orphan Designation: | Treatment of Primary Biliary Cholangitis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Ipsen Bioscience Inc. One Main Street, 7th Floor Cambridge, Massachusetts 02142 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-